糖尿病新世界
糖尿病新世界
당뇨병신세계
Diabetes New World
2015年
20期
13-15
,共3页
黄芪益肾颗粒%临床期糖尿病肾病%可行性
黃芪益腎顆粒%臨床期糖尿病腎病%可行性
황기익신과립%림상기당뇨병신병%가행성
Astragalus kidney particles%The clinical stage of diabetic nephropathy%The feasibility of
目的:探讨选择黄芪益肾颗粒对临床期糖尿病肾病患者完成治疗后获得的临床效果。方法选择该院2013年6月—2015年6月临床期糖尿病肾病患者106例。通过抽签法对糖尿病肾病患者进行随机分组。B2组(对照组53例)选择常规药物治疗的方法;B1组(观察组53例)在B2组基础上选择黄芪益肾颗粒进行治疗。比较所有糖尿病肾病患者在治疗总有效率以及空腹血糖等相关指标方面表现出的差异。结果所有临床期糖尿病肾病患者完成治疗后,在临床治疗总有效率方面,B1组明显高于B2组糖尿病肾病患者(P<0.05);在临床指标方面,B1组明显优于B2组糖尿病肾病患者(P<0.05)。结论针对临床期糖尿病肾病患者,选择黄芪益肾颗粒进行治疗,能够有效发挥益气补阴以及活血降浊的效果,最终将糖尿病肾病患者的生活质量有效提高。
目的:探討選擇黃芪益腎顆粒對臨床期糖尿病腎病患者完成治療後穫得的臨床效果。方法選擇該院2013年6月—2015年6月臨床期糖尿病腎病患者106例。通過抽籤法對糖尿病腎病患者進行隨機分組。B2組(對照組53例)選擇常規藥物治療的方法;B1組(觀察組53例)在B2組基礎上選擇黃芪益腎顆粒進行治療。比較所有糖尿病腎病患者在治療總有效率以及空腹血糖等相關指標方麵錶現齣的差異。結果所有臨床期糖尿病腎病患者完成治療後,在臨床治療總有效率方麵,B1組明顯高于B2組糖尿病腎病患者(P<0.05);在臨床指標方麵,B1組明顯優于B2組糖尿病腎病患者(P<0.05)。結論針對臨床期糖尿病腎病患者,選擇黃芪益腎顆粒進行治療,能夠有效髮揮益氣補陰以及活血降濁的效果,最終將糖尿病腎病患者的生活質量有效提高。
목적:탐토선택황기익신과립대림상기당뇨병신병환자완성치료후획득적림상효과。방법선택해원2013년6월—2015년6월림상기당뇨병신병환자106례。통과추첨법대당뇨병신병환자진행수궤분조。B2조(대조조53례)선택상규약물치료적방법;B1조(관찰조53례)재B2조기출상선택황기익신과립진행치료。비교소유당뇨병신병환자재치료총유효솔이급공복혈당등상관지표방면표현출적차이。결과소유림상기당뇨병신병환자완성치료후,재림상치료총유효솔방면,B1조명현고우B2조당뇨병신병환자(P<0.05);재림상지표방면,B1조명현우우B2조당뇨병신병환자(P<0.05)。결론침대림상기당뇨병신병환자,선택황기익신과립진행치료,능구유효발휘익기보음이급활혈강탁적효과,최종장당뇨병신병환자적생활질량유효제고。
Objective To study the choice astragalus kidney particles after treatment in patients with clinical stage of diabetic nephropathy have clinical effect. Methods Our hospital in 2013 June to 2015 June 106 patients with clinical stage of diabetic nephropathy. Through the draw method for randomized patients with diabetic nephropathy. B2 group (the control group (53 cases) choose the method of conventional drug treatment; B1 (observation group (53 cases) on the basis of B2 group choose astragalus treated kidney particles. Compare all the total effective rate in the treatment of diabetic nephropathy patients and fasting plasma glucose and other related indicators show the difference. Results All clinical stage of diabetic nephropathy after completion of treatment in the clinical total effective rate, B1 group is significantly higher than B2 diabetic nephropathy patients (P<0.05); In clinical indicators, B1 B2 is obviously better than the group of diabetic nephropathy patients (P<0.05). Conclusion According to the clinical stage of diabetic nephropathy patients, select the astragalus membranaceus kidney pellet treatment, can effectively exert the effect of yiqi Yin and invigorate the circulation of material supplement, will eventually improve on the quality of life of diabetic nephropathy patients.